August 7, 2022
In response to the Senate passing the Inflation Reduction Act, ACHP President and CEO Ceci Connolly issued the following statement:
“The Alliance of Community Health Plans applauds the Senate for passing the Inflation Reduction Act: an important step toward providing relief to families struggling to pay everyday bills. The legislation ensures millions of Americans will retain access to high-quality coverage and care they deserve while reducing the burden of out-of-control drug costs for seniors. For over a year, ACHP’s Board has pushed for comprehensive reforms to make therapies more affordable for working families—the only national payer group to do so—and we commend Senate leadership for making this a top priority.
“We urge House lawmakers to swiftly pass this landmark package to protect Americans’ access to affordable coverage and care.
“The drug pricing reforms within this package are a step in the right direction for holding pharmaceutical companies accountable for their egregious pricing practices. However, without provisions to penalize pharmaceutical companies for shifting costs to consumers with private health insurance, pharma has a chance to exploit this loophole and further strain Americans’ wallets.
“The Alliance of Community Health Plans calls on Congress to immediately introduce and move stand-alone legislation to protect consumers and meaningfully improve prescription drug affordability across the health care system.”
ABOUT ACHP
The Alliance of Community Health Plans (ACHP) represents the nation’s top-performing nonprofit health companies, which serve tens of millions of Americans in 36 states and D.C. ACHP member plans collaborate with providers on high-quality coverage and care — leading the industry in practical reforms.
ACHP is the voice of a unique payer-provider partnership model advancing proven solutions that deliver better value for patients, employers and taxpayers. Contact us for case studies and data about member innovations and results.
###
New from ACHP:
- ACHP Statement on Drug Pricing
- Ending the Allure of Drug Advertising
- ACHP Letter to Dr. Oz on Deregulation in Health Insurance
- ACHP Comments on CMS Marketplace Integrity & Affordability Proposed Rule
- ACHP Statement on CY2026 MA and Part D Rate Notice
- ACHP Statement on Final CY2026 MA and Part D Rule